Chimia p. 634 - 639 (2004)
Update date:2022-08-05
Topics:
Boss, Christoph
Richard-Bildstein, Sylvia
Furnari, Rocco
Bourgeois, Jean-Marc
Corminboeuf, Olivier
Grisostomi, Corinna
Coppex, Lionel
Harris, Luke
Prade, Lars
Meyer, Solange
Binkert, Christoph
Fischli, Walter
Brun, Reto
Weller, Thomas
Malaria is a very serious infectious disease affecting over two billion people worldwide. Currently available antimalarial drugs are losing effectiveness due to the emergence and the spread of resistant parasite strains. In order to regain control over the disease, new treatments are urgently needed. Drug discovery efforts in this direction are most likely to be successful if they target a novel mechanism of action. Such approaches will lead to antimalarial medicines that are functionally and structurally different from the existing drugs and therefore will have the potential to overcome existing resistances. Our own efforts are focused on the aspartic protease plasmepsin II (PMII) which is a promising new drug target for future antimalarial therapies. We have found structurally simple, moderately active, non-peptide inhibitors of plasmepsin II which offer ample opportunity for further optimization efforts.
View Morewebsite:http://www.guarson.com
Contact:+86-523-88059600,+86-13805268803
Address:Room B1006,Yafang Building,Jiangyan Avenue,Jiangyan District, Taizhou City,Jiangsu,China
Jiaxing Taixin Pharmaceutical Chemical Co., Ltd
Contact:0573-82613601
Address:Chemical Park, Jiaxing, Zhejiang, China
FREEBARQUE DEVELOPMENT GROUP LIMITED
Contact:+86(0)10-5109 5335 or 5109 5345
Address:Room602,Block1-B,LINGDI OFFICE,NO.13 BEIYUAN ROAD
Contact:+86-535-8888888
Address:No.161 Haishi Rd.
Beijing Century Richap Chemistry Co.,Ltd
Contact:+86- 010-64455497
Address:Guannan County, Lianyungang City, Jiangsu Province, China
Doi:10.1016/S0040-4020(01)88339-3
(1992)Doi:10.1016/S0040-4039(01)87939-9
(1969)Doi:10.1016/S0022-328X(00)93826-9
(1980)Doi:10.1021/ja00800a059
(1973)Doi:10.1021/jo00916a009
(1974)Doi:10.1002/jhet.5570100319
(1973)